Breast Disease Diagnosis and Therapy Markets: Europe and Asia-Pacific
241 Pages |
95 Exhibits |
Forecasts Through 2014
Order individually or subscribe to Medtech Pro and get a complete intel platform.
Overview
The market for breast cancer detection, diagnosis, and treatment is well-developed in the U.S. and much of Europe. It has remained relatively under-developed in the Asia-Pacific region, however, although recent trends suggest that the opportunities for device manufacturers are improving, driven by the growing prevalence of breast disease in these countries.In the U.S. and Europe, mammography is the standard of care for the early detection of breast cancer. Broader adoption is expected in the Asia-Pacific region, however, which will contribute to higher rates of detection. Outside of the U.S., the vast majority of ultrasound and magnetic resonance imaging (MRI) systems are used for general radiology and are not dedicated specifically to imaging the breast. The ability of these systems to differentiate between tissue types that cannot be distinguished by mammography should contribute to incremental sales in Europe and the Asia-Pacific region. Higher rates of detection resulting from the broader adoption of imaging systems should contribute to sales of biopsy devices, which are used to confirm the presence of breast cancer.
This report covers the market for the detection, diagnosis, and treatment of breast disease in selected countries in Europe and the Asia-Pacific region through 2014, and provides an in-depth analysis of the economic and clinical factors driving sales of mammography, ultrasound, MRI and contrast-enhanced imaging products, and interventional devices.
Companies Covered
AlokaAurora Imaging Technology
B-K Medical
Carestream Health
CR Bard
Esaote
FUJIFILM Medical Systems
General Electric
Hitachi
Hologic
i-CAD
Johnson & Johnson (Ethicon Endosurgery and Ethicon)
Mindray
Philips Electric
SenoRx
Siemens
Toshiba
Table of Contents
1. EXECUTIVE SUMMARY 1.1 Clinical Background and Statistics 1.2 Factors Affecting the Market for Breast Cancer 1.3 Product Markets 1.3.1 Mammography 1.3.2 Ultrasound 1.3.2.1 Challenges to the Adoption of Ultrasound 1.3.2.2 MRI & Contrast-Enhanced Imaging 1.3.3 Interventional Procedures 1.4 Procedure and Market Forecasts Exhibit 1-1: Global Rates of Incidence and Survival for Breast Cancer Exhibit 1-2: Global Economic Statistics Exhibit 1-3: Mammography Procedure Forecast by Region, 2008-2014 Exhibit 1-4: Ultrasound Procedure Forecast by Region, 2008-2014 Exhibit 1-5: MRI Procedure Forecast by Region, 2008-2014 Exhibit 1-6: Biopsy Procedure Forecast by Region, 2008-2014 Exhibit 1-7: Breast Diag. & Ther. Device Sales in Europe, 2008-2014 Exhibit 1-8: Breast Diag. & Ther. Device Sales in Asia-Pacific, 2008-2014 2. BREAST DISEASE - BACKGROUND AND STATISTICS 2.1 Breast Anatomy 2.2 Malignant Breast Disease 2.2.1 Invasive Breast Cancer 2.2.2 Ductal Carcinoma in situ 2.2.3 Atyp. Ductal Hyperplasia/Atyp. Lobular Hyperplasia 2.2.4 Tumor Staging 2.3 Risk Factors: Breast Cancer 2.4 Disease Prevalence and Forecasts 2.5 Benign Breast Disease 2.5.1 Fibroadenoma 2.5.2 Cyst 2.5.3 Fibrocystic Disease 2.5.4 Benign Papilloma 2.6 Summary Exhibit 2-1: Breast Anatomy and Malignant Disease States Exhibit 2-2: Inconsistency in DCIS/ADH Diagnosis Exhibit 2-3: Breast Cancer Staging and Survivability Exhibit 2-4: Breast Cancer Staging and Treatment Options Exhibit 2-5: Worldwide Distribution of Breast Cancer Exhibit 2-6: Breast Cancer Diagnosis & Mortality, Trends & Forecasts 3. REGIONAL FACTORS AFFECTING BREAST CANCER MORTALITY 3.1 Regional Factors Affecting Breast Cancer Mortality 3.2 Economics, Screening, Incidence, and Lifestyle 3.3 Healthcare Payment: Public vs. Private 3.4 Distribution 3.5 Geopolitical Regions 3.5.1 Europe 3.5.1.1 France 3.5.1.2 Germany 3.5.1.3 United Kingdom 3.5.1.4 Scandinavian Countries 3.5.1.5 Other Countries, Northern/Western Europe 3.5.1.6 Countries in Southern/Western Europe 3.5.1.7 Countries of the Former Soviet Union 3.5.2 Asia-Pacific 3.5.2.1 China 3.5.2.2 India 3.5.2.3 Japan 3.5.2.4 Australia/New Zealand 3.5.2.5 Rest of Asia Exhibit 3-1: Severity of Cancer: Diagnosis, Mortality, and Early Detection Exhibit 3-2: European Regions Covered in this Report Exhibit 3-3: European Population Forecast, 2008 to 2014 Exhibit 3-4: Relevant Economic Statistics in Europe Exhibit 3-5: Rates of Incidence and Survival for Breast Cancer in Europe Exhibit 3-6: Mammography Frequency and Compliance in Europe Exhibit 3-7: Hospital Beds per 1,000,000 Population in Europe, 1996-2014 Exhibit 3-8: Countries Included in the Asia-Pacific Region Exhibit 3-9: Insured and Uninsured Populations in China Exhibit 3-10: Population Forecasts for Asia-Pacific Countries, 2008-2014 Exhibit 3-11: Economic Demographics in the Asia-Pacific Region Exhibit 3-12: Millionaires in Different Countries and Regions During 2008 Exhibit 3-13: Breast Cancer Screening in the Asia-Pacific Region in 2008 Exhibit 3-14: Number of Hospitals in India and the U.S. 4. MAMMOGRAPHY 4.1 Devices Costs 4.2 Screening and Diagnostic Mammography 4.3 Mammography Process 4.3.1 Image Acquisition 4.3.2 Detection (Screening) vs. Diagnosis 4.3.3 Certifications for Radiologists 4.3.4 Viewing the Images 4.3.5 Diagnostic Exam 4.4 Reimbursement 4.5 Product Offerings 4.5.1 Image Acquisition Systems 4.5.1.1 Types of Detector 4.5.1.1.1 Direct vs Indirect Capture 4.5.1.1.2 Resolution 4.5.1.1.3 Radiation Exposure 4.5.1.1.4 Cost 4.5.2 Market Analysis 4.5.2.1 France 4.5.2.2 Germany 4.5.2.3 United Kingdom 4.5.2.4 Scandinavian Countries 4.5.2.5 Countries of Southern / Western Europe 4.5.2.6 Countries of the Former Soviet Bloc 4.5.2.7 China 4.5.2.8 India 4.5.2.9 Japan 4.5.2.10 Australia/New Zealand 4.5.2.11 Rest of Asia 4.5.3 Product and Service Revenues 4.5.3.1 Europe 4.5.3.1.1 Suppliers Shares in Europe 4.5.3.2 Asia-Pacific 4.5.3.2.1 Supplier Shares in Asia-Pacific Exhibit 4-1: Mammography Exhibit 4-2: Reduction in Tumor Size: Screening Mammography Programs Exhibit 4-3: Insurance Reimbursement Programs in 2008 Exhibit 4-4: Mammography Process Exhibit 4-5: Selected Reimbursement Programs in Europe and Asia-Pacific Exhibit 4-6: Digital versus Analog Mammography Systems - Image Quality Exhibit 4-7: Digital Mammography Systems by Type of Detector Exhibit 4-8: Systems, Resolutions, and Radiation Levels in 2008 Exhibit 4-9: Mammography Procedure Forecast by Region, 2008-2014 Exhibit 4-10: Installed Base, Mammography Systems, 2008-2014 Exhibit 4-11: Decrease in Mortality from U.K. Screening Program, 1995-2004 Exhibit 4-12: Mammography Systems in Europe, Installed Base, 2008-2014 Exhibit 4-13: Mammography Systems in Europe, Unit Forecast, 2008-2014 Exhibit 4-14: Analogue Sales Forecast in Europe, 2008-2014 Exhibit 4-15: CR Device Sales Forecast in Europe, 2008-2014 Exhibit 4-16: FFD Device Sales Forecast in Europe, 2008-2014 Exhibit 4-17: Mammography System Sales in Europe, 2008-2014 Exhibit 4-18: Supplier Shares in Europe, 2008 Exhibit 4-19: Mammography Systems, Asia-Pacific, Installed Base, 2008-2014 Exhibit 4-20: Mammography Systems, Asia-Pacific, Unit Forecast, 2008-2014 Exhibit 4-21: Analogue Sales Forecast in Asia-Pacific, 2008-2014 Exhibit 4-22: CR Device Sales Forecast in Asia-Pacific, 2008-2014 Exhibit 4-23: FFD Device Sales in Asia-Pacific, 2008-2014 Exhibit 4-24: Mammography System Sales in Asia-Pacific, 2008-2014 Exhibit 4-25: Supplier Shares in Asia-Pacific, 2008 5. ULTRASOUND 5.1 International Markets for Breast Ultrasound Products 5.1.1 Product Types 5.2 The Procedure 5.2.1 Screening 5.2.2 Guided Biopsy 5.2.3 Wire Location 5.3 Additional Capabilities 5.3.1 Elastography 5.3.2 CAD 5.3.3 Image Fusion 5.4 Regional Procedure & Market Forecasts 5.4.1 Europe 5.4.1.1 France, Germany, the U.K., and Other Countries in Northern/Western Europe 5.4.1.2 Scandinavian Countries 5.4.1.3 Southern/Western European Countries 5.4.1.4 Countries of the Former Soviet Bloc 5.4.1.5 Supplier Shares in Europe 5.4.2 Asia-Pacific 5.4.2.1 China 5.4.2.2 India 5.4.2.3 Japan 5.4.2.4 South Korea 5.4.2.5 Australia / New Zealand 5.4.2.6 Rest of Asia 5.4.2.7 Supplier Shares in Asia-Pacific Exhibit 5-1: Ultrasound Procedures Exhibit 5-2: Mammography & Ultrasound, Dense & Fatty-Replaced Breasts Exhibit 5-3: Breast Ultrasound Images Exhibit 5-4: Ultrasound in the Dense Breast Exhibit 5-5: Ultrasound Procedures Performed in Europe during 2008 Exhibit 5-6: Ultrasound Procedure Forecast for Europe, 2008-2014 Exhibit 5-7: Installed Base of Breast Ultrasound Systems in Europe, 2008-2014 Exhibit 5-8: Ultrasound Units Sold in Europe, 2008-2014 Exhibit 5-9: Breast Ultrasound Systems, European Sales Forecast, 2008-2014 Exhibit 5-10: Breast Ultrasound Systems, Sales by Region in Europe, 2008-2014 Exhibit 5-11: Supplier Shares in Europe, 2008 Exhibit 5-12: Ultrasound Procedures Performed in Asia-Pacific during 2008 Exhibit 5-13: Ultrasound Procedure Forecast for Asia-Pacific, 2008-2014 Exhibit 5-14: Installed Base, Breast Ultrasound Systems in Asia-Pacific, 2008-2014 Exhibit 5-15: Ultrasound Units Sold in Asia-Pacific, 2008-2014 Exhibit 5-16: Breast Ultrasound Systems, Asia-Pacific Sales Forecast, 2008-2014 Exhibit 5-17: Breast Ultrasound System Sales in Asia-Pacific, 2008-2014 Exhibit 5-18: Supplier Shares in Asia-Pacific, 2008 6. CONTRAST-ENHANCED IMAGING PRODUCTS 6.1 Magnetic Resonance Imaging 6.1.1 Clinical and Economic Challenges 6.1.1.1 Clinical Challenges 6.1.1.2 Economic Challenges 6.1.1.3 Other Factors 6.2 Procedure & Market Forecasts for Europe 6.2.1 Supplier Shares 6.3 Procedures & Market Forecasts, Asia-Pacific 6.3.1 Supplier Shares in the Asia-Pacific Region 6.4 Breast Specific Gamma Imaging (BSGI) Exhibit 6-1: MRI Systems per Million Inhabitants in Europe, 2008-2014 Exhibit 6-2: European Procedure Forecast, 2008-2014 Exhibit 6-3: MRI Systems, European Unit Forecast, 2008-2014 Exhibit 6-4: European Sales Forecast, Breast-Enabled MRI Products, 2008-2014 Exhibit 6-5: Supplier Shares in Europe, 2008 Exhibit 6-6: MRI Systems per Million Inhabitants, Asia-Pacific Region, 2008-2014 Exhibit 6-7: Procedure Forecast for the Asia-Pacific Region, 2008-2014 Exhibit 6-8: MRI Systems, Unit Forecast for the Asia-Pacific Region, 2008-2014 Exhibit 6-9: Sales Forecast in Asia-Pacific, Breast-Enabled MRI, 2008-2014 Exhibit 6-10: Sales Forecast in Asia-Pacific (Excl. China and India), 2008-2014 Exhibit 6-11: Supplier Shares in the Asia-Pacific Region, 2008 7. INTERVENTIONAL PROCEDURES & PRODUCTS 7.1 Biopsy 7.1.1 Clinical Results 7.1.2 Histopathology 7.1.3 Cytopathology 7.1.4 Biopsy Methods 7.1.4.1 Spring-Loaded Core Needle Biopsy 7.1.4.2 Vacuum-Assisted Biopsy 7.1.4.2.1 Selected Devices 7.1.4.3 Fine Needle Aspiration 7.1.5 Biopsy Marking Devices 7.2 Alternatives to Biopsy: Breast-Specific Antigens 7.3 Brachytherapy 7.4 Procedure Forecasts and Market Analyses 7.4.1 Vacuum-Assisted Biopsy 7.4.2 Spring-Loaded Core Needle Biopsy 7.4.3 Brachytherapy 7.4.4 European Analysis 7.4.4.1 France, Germany, the U.K., and Other 7.4.4.2 Scandinavian Countries 7.4.4.3 Countries in Southern / Western Europe 7.4.4.4 Countries of the Former Soviet Bloc 7.4.5 Asia-Pacific 7.4.6 Product Sales in the European Region 7.4.6.1 Vacuum Assisted Biopsy Products 7.4.6.1.1 Supplier Shares 7.4.6.2 Spring-Loaded Biopsy Devices 7.4.7 Product Sales in the Asia-Pacific Region 7.4.7.1 Vacuum-Assisted Biopsy Products 7.4.7.1.1 Supplier Shares 7.4.7.2 Spring-Loaded Biopsy Devices Exhibit 7-1: Core Needle Biopsy Devices Exhibit 7-2: Relative Volumes of Biopsy Device Specimens Exhibit 7-3: Vacuum-Assisted Biopsy Procedure Forecast in Europe, 2008-2014 Exhibit 7-4: Vacuum-Assisted Biopsy Procedure Forecast, Asia-Pacific, 2008-2014 Exhibit 7-5: Spring-Loaded Biopsy Procedure Forecast in Europe, 2008-2014 Exhibit 7-6: Spring-Loaded Biopsy Procedure Forecast, Asia-Pacific, 2008-2014 Exhibit 7-7: Installed Base, Vac.-Assisted Biopsy Devices in Europe, 2008-2014 Exhibit 7-8: Vacuum-Assisted Biopsy Device Sales in Europe, 2008-2014 Exhibit 7-9: Supplier Shares in Europe, 2008 Exhibit 7-10: Spring-Loaded Biopsy Device Sales in Europe, 2008-2014 Exhibit 7-11: Installed Vac.-Assisted Biopsy Systems in Asia-Pacific, 2008-2014 Exhibit 7-12: Vac.-Assisted Biopsy Sales in the Asia-Pacific Region, 2008-2014 Exhibit 7-13: Supplier Shares in the Asia-Pacific Region, 2008 8. COMPANY PROFILES 8.1 Aloka 8.2 Aurora Imaging Technology 8.3 B-K Medical 8.4 Carestream Health 8.5 CR Bard 8.6 Esaote 8.7 FUJIFILM Medical Systems 8.8 General Electric 8.9 Hitachi 8.10 Hologic 8.11 i-CAD 8.12 Johnson & Johnson (Ethicon Endosurgery and Ethicon) 8.13 Mindray 8.14 Philips Electric 8.15 SenoRx 8.16 Siemens 8.17 Toshiba
